Clearpoint Neuro Inc
CLPT14.020USD
-0.470-3.24%
收盘 12/26, 16:00（美东）报价延迟15分钟
398.56M总市值
亏损市盈率 TTM
关于 Clearpoint Neuro Inc 公司
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
Clearpoint Neuro Inc简介
公司代码CLPT
公司名称Clearpoint Neuro Inc
上市日期Jul 03, 2019
CEOBurnett (Joseph Michael)
员工数量115
证券类型Ordinary Share
年结日Jul 03
公司地址120 S. Sierra Avenue
城市SOLANA BEACH
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92075
电话19499006833
网址https://www.clearpointneuro.com/
公司代码CLPT
上市日期Jul 03, 2019
CEOBurnett (Joseph Michael)
Clearpoint Neuro Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.87K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.08K
-14.51%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mr. Jeremy L. Stigall
Mr. Jeremy L. Stigall
Chief Business Officer
Chief Business Officer
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.87K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.08K
-14.51%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Products: Functional neurosurgery
3.43M
37.24%
Services: Biologics and drug delivery
2.87M
31.12%
Products: Biologics and drug delivery
1.87M
20.30%
Product Systems and software products
694.00K
7.53%
Services: Capital equipment and other
350.00K
3.80%
地区USD
名称
营收
占比
United States
9.21M
100.00%
业务
地区
业务USD
名称
营收
占比
Products: Functional neurosurgery
3.43M
37.24%
Services: Biologics and drug delivery
2.87M
31.12%
Products: Biologics and drug delivery
1.87M
20.30%
Product Systems and software products
694.00K
7.53%
Services: Capital equipment and other
350.00K
3.80%
股东统计
更新时间: 11月18日 周二
更新时间: 11月18日 周二
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.47%
The Vanguard Group, Inc.
5.03%
Bigger Capital Funds, LP
4.34%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
其他
79.94%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.47%
The Vanguard Group, Inc.
5.03%
Bigger Capital Funds, LP
4.34%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
其他
79.94%
股东类型
持股股东
占比
Investment Advisor
20.66%
Investment Advisor/Hedge Fund
9.97%
Hedge Fund
7.85%
Individual Investor
4.98%
Corporation
3.01%
Research Firm
1.38%
Bank and Trust
0.10%
Pension Fund
0.03%
Insurance Company
0.02%
其他
52.01%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
238
11.91M
42.82%
-795.00
2025Q3
241
11.91M
44.93%
+805.07K
2025Q2
228
11.11M
37.29%
+1.29M
2025Q1
216
9.82M
36.04%
-268.85K
2024Q4
204
9.20M
33.04%
+1.04M
2024Q3
190
8.15M
32.05%
-235.56K
2024Q2
185
8.39M
33.08%
-454.38K
2024Q1
183
8.85M
30.95%
+359.48K
2023Q4
183
7.82M
35.41%
+717.11K
2023Q3
184
7.11M
35.71%
+336.40K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.50M
5.27%
+1.13M
+307.45%
Jun 30, 2025
The Vanguard Group, Inc.
1.48M
5.19%
+191.14K
+14.89%
Jun 30, 2025
Bigger Capital Funds, LP
1.17M
4.1%
+31.67K
+2.79%
Jun 30, 2025
PTC Therapeutics Inc
894.58K
3.15%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
624.80K
2.2%
+323.43K
+107.32%
Jun 30, 2025
State Street Investment Management (US)
333.38K
1.17%
+207.53K
+164.91%
Jun 30, 2025
Bigger (Michael)
378.69K
1.33%
--
--
Jun 30, 2025
Brown Advisory
330.90K
1.16%
-191.00
-0.06%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
1.19%
iShares Neuroscience and Healthcare ETF
0.94%
iShares Micro-Cap ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
Vanguard US Momentum Factor ETF
0.06%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比1.19%
iShares Neuroscience and Healthcare ETF
占比0.94%
iShares Micro-Cap ETF
占比0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.09%
Vanguard US Momentum Factor ETF
占比0.06%
Motley Fool Next Index ETF
占比0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.03%
iShares Russell 2000 Growth ETF
占比0.03%
iShares Russell 2000 ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Clearpoint Neuro Inc的前五大股东是谁？
Clearpoint Neuro Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：1.50M，占总股份比例：5.27%。
The Vanguard Group, Inc.持有股份：1.48M，占总股份比例：5.19%。
Bigger Capital Funds, LP持有股份：1.17M，占总股份比例：4.10%。
PTC Therapeutics Inc持有股份：894.58K，占总股份比例：3.15%。
Geode Capital Management, L.L.C.持有股份：624.80K，占总股份比例：2.20%。
BlackRock Institutional Trust Company, N.A.持有股份：1.50M，占总股份比例：5.27%。
The Vanguard Group, Inc.持有股份：1.48M，占总股份比例：5.19%。
Bigger Capital Funds, LP持有股份：1.17M，占总股份比例：4.10%。
PTC Therapeutics Inc持有股份：894.58K，占总股份比例：3.15%。
Geode Capital Management, L.L.C.持有股份：624.80K，占总股份比例：2.20%。
Clearpoint Neuro Inc的前三大股东类型是什么？
Clearpoint Neuro Inc 的前三大股东类型分别是：
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Bigger Capital Funds, LP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Bigger Capital Funds, LP
有多少机构持有Clearpoint Neuro Inc(CLPT)的股份？
截至2025Q4，共有238家机构持有Clearpoint Neuro Inc的股份，合计持有的股份价值约为11.91M，占公司总股份的42.82%。与2025Q3相比，机构持股有所增加，增幅为-2.11%。
哪个业务部门对Clearpoint Neuro Inc的收入贡献最大？
在FY2025Q2，Products: Functional neurosurgery业务部门对Clearpoint Neuro Inc的收入贡献最大，创收3.43M，占总收入的37.24%。
